- Home
- CCCC vs MHH Comparison
CCCC vs MHH Comparison
Compare CCCC & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- MHH
- Stock Information
- Founded
- CCCC 2015
- MHH 1986
- Country
- CCCC United States
- MHH United States
- Employees
- CCCC N/A
- MHH N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- MHH Professional Services
- Sector
- CCCC Health Care
- MHH Consumer Discretionary
- Exchange
- CCCC Nasdaq
- MHH Nasdaq
- Market Cap
- CCCC 104.4M
- MHH 87.6M
- IPO Year
- CCCC 2020
- MHH N/A
- Fundamental
- Price
- CCCC $1.54
- MHH $7.06
- Analyst Decision
- CCCC Buy
- MHH
- Analyst Count
- CCCC 3
- MHH 0
- Target Price
- CCCC $12.00
- MHH N/A
- AVG Volume (30 Days)
- CCCC 1.0M
- MHH 11.9K
- Earning Date
- CCCC 07-31-2025
- MHH 08-06-2025
- Dividend Yield
- CCCC N/A
- MHH N/A
- EPS Growth
- CCCC N/A
- MHH N/A
- EPS
- CCCC N/A
- MHH 0.17
- Revenue
- CCCC $39,783,000.00
- MHH $200,437,000.00
- Revenue This Year
- CCCC N/A
- MHH $1.22
- Revenue Next Year
- CCCC N/A
- MHH $5.41
- P/E Ratio
- CCCC N/A
- MHH $38.71
- Revenue Growth
- CCCC 98.56
- MHH 3.93
- 52 Week Low
- CCCC $1.09
- MHH $6.20
- 52 Week High
- CCCC $7.66
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- CCCC 50.55
- MHH 50.53
- Support Level
- CCCC $1.36
- MHH $6.56
- Resistance Level
- CCCC $1.63
- MHH $6.85
- Average True Range (ATR)
- CCCC 0.14
- MHH 0.37
- MACD
- CCCC -0.00
- MHH 0.07
- Stochastic Oscillator
- CCCC 38.33
- MHH 96.24
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.